NOCD

NOCD

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://www.treatmyocd.com

Last Round

Series C

Jan 31, 2023

Est. Valuation

$19.96M

Total Funding Raised

$84M

Momentum Score

25 /100

Company Overview

NOCD is a mental health technology company that offers a telehealth application to help individuals self-treat and monitor their obsessive-compulsive disorder symptoms through guided cognitive-behavioral therapy exercises.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Mental Health, Patient Engagement

Business Model

B2B2C

Customer Profile

Payment Processing Fee, Freemium

AI Layer

Non-AI

Keywords

OCD treatmentERP therapyExposure and Response Preventiontelehealth platformvirtual mental healthonline therapyOCD appspecialty care platformbehavioral healthin-network therapypeer support communityPTSD treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NOCD Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NOCD Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJan 31, 2023
Series BSep 21, 2021
Series AOct 8, 2020
Series AOct 1, 2019
SeedFeb 12, 2018

Key People

Founding team and executive leadership

Ilyas Patanam

Cofounder Chief Growth Officer

Founding Team

Stephen Smith

Co-Founder And Chief Executive Officer

Founding Team

Matthew Thorne

Chief Financial Officer

Executive Team

NOCD Investors

Notable investors and investment history

InvestorRounds
Longitude CapitalSeries C
Meridian Street CapitalSeries A
Chicago VenturesSeries A, Series B
Kaiser Permanente VenturesSeries C, Series B
F-Prime CapitalSeries C, Series B
7wire VenturesSeries A, Series C
Cigna VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 28, 2026

    Acquired virtual trauma therapy provider Rebound Health.

  • May 6, 2025

    Achieved 90% commercial insurance coverage in the U.S.

NOCD Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NOCD Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NOCD's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range717
Year Founded2014
Last FundingJan 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.